招商蛇口(001979.SZ)獲准配股 內房在岸融資渠道重啟在望
國營內房招商蛇口(001979.SZ)上周末宣布獲中證監許可配發新股集資最多85億元人民幣,屬內地去年11月撤銷內房股本融資禁令以來,首宗內房在岸股本集資,令市場對激活內房主要融資渠道的憧憬升溫。
自2015年起內房被禁止進行在岸股本集資,以避免資金用於買地。
以今年銷售計,招商蛇口是內地第六大內房,其去年12月指擬向深圳市政府旗下公司配股,獲得資金用於現有物業項目及償債。
現時最少五家內房擬進行類似股本融資,大多有國企背景。保利發展(600048.SH)屬至今獲股票交易所許可的內房中擬集資額最高;惟仍等待中證監許可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.